您的位置：
首页
>
农业专利
>
详情页
ANTICORPS À CHAÎNE UNIQUE MG7 SE LIANT SPÉCIFIQUEMENT À UN CEA HAUTEMENT GLYCOSYLÉ ET SON UTILISATION DANS LA DÉTECTION ET LE TRAITEMENT
专利权人:
The Fourth Military Medical University;Shanghai Genechem Co., Ltd.
发明人:
FAN, Daiming,NIE, Yongzhan,WU, Kaichun,CAO, Yueqiong,YUAN, Jijun,YU, Xuejun
申请号：
EP17833578
公开号：
EP3492497A4
申请日:
2017.07.27
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention provides a glycosylated CEA-specific single-chain antibody, and a chimeric antigen receptor (CAR) targeting a glycosylated CEA, which can be used in manufacture of an agent or a medicament for diagnosis or treatment of a tumor overexpressing glycosylated CEA.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
Recombinant immunotoxin targeting carcinoembryonic antigen and pharmaceutical composition for preventing or treating cancer comprising the same
CORRELATES OF EFFICACY RELATING TO TUMOR VACCINES
Multispecific binding proteins targeting CAIX, ANO1, mesothelin, TROP2, CEA or claudin-18.2.
Multispecific binding proteins targeting CAIX, ANOl, mesothelin,TROP2, CEA, or claudin-18.2
Multispecific Binding Proteins Targeting CAIX, ANO1, Mesothelin, TROP2, CEA, or Cladin-18.2
